Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients.
Michael BoyiadzisMei-Jie ZhangKaren ChenHisham Abdel-AzimMuhammad Bilal AbidMahmoud AljurfUlrike BacherTalha BadarSherif M BadawyMinoo BattiwallaNelli BejanyanVijaya Raj BhattValerie I BrownPaul CastilloJan CernyEdward A CopelanCharles F CraddockBhagirathbhai R DholariaMiguel Angel Diaz PerezChristen L EbensRobert Peter GaleSiddhartha GangulyLohith GowdaMichael R GrunwaldShahrukh HashmiGerhard Carl HildebrandtMadiha IqbalOmer JamyMohamed A Kharfan-DabajaNandita KheraHillard M LazarusRichard J LinDipenkumar ModiSunita NathanTaiga NishihoriSagar S PatelAttaphol PawarodeWael SaberAkshay SharmaMelham M SolhJohn L WagnerTrent P WangKirsten M WilliamsLena E WinestoneBaldeep WirkAmer ZeidanChristopher S HouriganMark R LitzowPartow KebriaeiMarcos de LimaKristin PageDaniel J WeisdorfPublished in: Leukemia (2023)
Keyphrases
- end stage renal disease
- acute myeloid leukemia
- ejection fraction
- newly diagnosed
- chronic kidney disease
- stem cell transplantation
- peritoneal dialysis
- prognostic factors
- allogeneic hematopoietic stem cell transplantation
- metabolic syndrome
- high dose
- low dose
- patient reported outcomes
- adipose tissue
- skeletal muscle
- patient reported
- weight loss